FCGR2A and metastatic malignant neoplasm: FCGR2A and KLHDC8B in TEPs were positively related to metastatic cancers in comparison with healthy controls and had potential diagnostic significance for metastatic cancers with a sensitivity of 61.8%, 59.7%, and a specificity of 89.1%, 83.6%, respectively.